Prof. dr. Bob van de Water

Prof. Dr. Bob van de Water is head of the Cancer Therapeutics and Drug Safety group at the Division of Drug Discovery & Safety.

Contact Bob van de Water

Exposome-Scan

Exposome-Scan

The unique and large-scale open facility Exposome-Scan gives researchers from all over the Netherlands the opportunity to study the exposome. Anyone who submits a good research request will have access to the research facility and will be able to conduct research at Exposome-Scan at cost price. The facility in Leiden opens on 15 February 2024 and builds on the knowledge gained in the Exposome-NL and X-omics research programmes.

Read More